TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
1315.79%
↑ 2136% above average
Average (39q)
58.85%
Historical baseline
Range
High:1315.79%
Low:-112.50%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 1315.79% |
| Q2 2025 | 450.72% |
| Q1 2025 | -78.44% |
| Q4 2024 | 433.33% |
| Q3 2024 | -36.84% |
| Q2 2024 | 164.89% |
| Q1 2024 | 26.80% |
| Q4 2023 | -112.50% |
| Q3 2023 | 335.29% |
| Q2 2023 | -21.43% |
| Q1 2023 | 28.21% |
| Q4 2022 | -50.00% |
| Q3 2022 | 13.33% |
| Q2 2022 | 41.18% |
| Q1 2022 | 27.14% |
| Q4 2021 | -7.69% |
| Q3 2021 | -10.17% |
| Q2 2021 | 14.49% |
| Q1 2021 | 2.82% |
| Q4 2020 | 2.74% |
| Q3 2020 | -55.32% |
| Q2 2020 | 2.08% |
| Q1 2020 | -17.07% |
| Q4 2019 | 40.58% |
| Q3 2019 | -64.29% |
| Q2 2019 | 2.33% |
| Q1 2019 | 36.76% |
| Q4 2018 | -58.14% |
| Q3 2018 | 29.51% |
| Q2 2018 | -3.39% |
| Q1 2018 | -28.26% |
| Q4 2017 | 4.17% |
| Q3 2017 | -6.67% |
| Q2 2017 | 13.46% |
| Q1 2017 | -8.33% |
| Q4 2016 | 4.00% |
| Q3 2016 | -51.52% |
| Q2 2016 | -17.86% |
| Q1 2016 | 24.32% |
| Q4 2015 | -32.14% |